Katelyn Michelle Horan, Clinical Nurse Specialist - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 2425 E Commercial Blvd Ste 405, Fort Lauderdale, FL 33308 Phone: 855-284-7483 Fax: 617-807-0958 |
Lisa Forman Becker, ARNP Clinical Nurse Specialist - Psych/Mental Health Medicare: Accepting Medicare Assignments Practice Location: 919 Ne 13th St, Fort Lauderdale, FL 33304 Phone: 954-763-2030 Fax: 954-763-9847 |
Sandra E Benter, ARNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2900 W Prospect Rd, Fort Lauderdale, FL 33309 Phone: 954-731-1000 Fax: 954-497-3857 |
Ms. Diane Marie Krawczyk, RNFA Clinical Nurse Specialist - Medical-Surgical Medicare: Not Enrolled in Medicare Practice Location: 3981 Sw 30th Ave, Fort Lauderdale, FL 33312 Phone: 954-816-9681 |
News Archive
The Life Sciences Discovery Fund (LSDF) today announced $600,000 in awards to four Washington state-based research teams to support commercial development of health-related technologies. The funded projects will concentrate on improving the success rate of lumbar punctures (spinal taps) in children; developing a safer and more effective magnetic resonance imaging (MRI) contrast agent; enhancing a DNA sequencing technology to profile T cells within the immune system; and developing a device to detect early stages of tooth decay.
Excessive weight gain during pregnancy increases the risk of suffering illnesses such as hypertension and gestational diabetes, or of having a premature birth or a birth by Caesarean; furthermore, it also has negative effects on the newly-born and increases the risk of infants being overweight by 30%.
The Cell Therapy Catapult has published its annual analysis of the UK preclinical and clinical research landscapes with the release of its UK Clinical and Pre-Clinical Trials Databases. These show a 24% rise in the number of clinical trials and an increase of 22% in the number of pre-clinical projects. Sector growth came in the key areas of oncology, neurology, ophthalmology and cardiovascular.
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.
Every year, nearly two million people in the United States suffer traumatic brain injury (TBI), the leading cause of brain damage and permanent disabilities that include motor dysfunction, psychological disorders, and memory loss. Current rehabilitation programs help patients but often achieve limited success.
› Verified 5 days ago